Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31
Phase 41

Trial Status

Other3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

34 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

European Institute of Oncology

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sandro Pignata, M.D., Ph.D.

National Cancer Institute, Naples

Moderately Similar
9 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchNational Cancer Institute, Naples
Collaborated on 3 trials
Similarity Score32%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Moderately Similar
13 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchNational Cancer Institute, Naples
Collaborated on 3 trials
Similarity Score32%

Gennaro Daniele, M.D., Ph.D.

National Cancer Institute, Naples

Moderately Similar
4 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchNational Cancer Institute, Naples
Collaborated on 3 trials
Similarity Score32%

Ciro Gallo, M.D.

University of Campania Luigi Vanvitelli

Moderately Similar
5 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchNational Cancer Institute, Naples
Collaborated on 3 trials
Similarity Score32%

Lei Li, M.D.

Peking Union Medical College Hospital

Moderately Similar
46 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer
Similarity Score30%

Michael B Gill

Power Life Sciences Inc.

Moderately Similar
105 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer
Similarity Score30%

Irene Floriani, Ph.D.

Mario Negri Institute

Related
2 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchNational Cancer Institute, Naples
Collaborated on 2 trials
Similarity Score28%

Roldano Fossati, M.D.

Mario Negri Institute

Related
2 trials

Shared therapeutic areas:

Ovary CancerRecurrent Ovarian Cancer

Worked with same sponsors:

Mario Negri Institute for Pharmacological ResearchNational Cancer Institute, Naples
Collaborated on 2 trials
Similarity Score28%

Ingrid Mayer, MD

Vanderbilt-Ingram Cancer Center

Related
13 trials

Shared therapeutic areas:

Ovary Cancer
Similarity Score15%

Ciro Gallo, M.D., Ph.D.

University of Campania Luigi Vanvitelli

Related
8 trials

Shared therapeutic areas:

Ovary Cancer

Worked with same sponsors:

National Cancer Institute, Naples
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03410784Phase 2PrincipalInvestigator

Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Ovarian Cancer
Unknown
NCT01706120Phase 4PrincipalInvestigator

Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab

Ovarian Cancer
Unknown
NCT01802749Phase 3PrincipalInvestigator

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer

Recurrent Ovarian Cancer
Unknown

All 3 trials loaded